Department of Neurology, Academic Medical Center, Amsterdam, the Netherlands.
BMC Neurol. 2010 Jun 7;10:38. doi: 10.1186/1471-2377-10-38.
Fabry patients have symptoms and signs compatible with autonomic dysfunction. These symptoms and signs are considered to be due to impairment of the peripheral nervous system, but findings indicative of autonomic neuropathy in other diseases, such as orthostatic intolerance and male sexual dysfunction, are infrequently reported in Fabry disease. The aim of our study was to investigate autonomic symptoms and cardiovascular autonomic function in a large cohort of male and female Fabry patients.
Forty-eight Fabry patients (15 male, 30 treated with enzyme replacement therapy) and 48 sex- and age-matched controls completed a questionnaire on autonomic symptoms (the Autonomic Symptom Profile). Thirty-six Fabry patients underwent cardiovascular function tests.
The Autonomic Symptom Profile revealed a significantly higher sum score in Fabry patients than in healthy control subjects (22 versus 12), but a relatively low score compared to patients with proven autonomic neuropathy. Fabry patients scored worse than healthy controls in the orthostatic intolerance domain. Scores in the male sexual dysfunction domain were comparable between healthy controls and male Fabry patients. The cardiovascular autonomic function tests revealed only mild abnormalities in seven patients. None of these seven patients showed more than one abnormal test result. Enzyme replacement therapy was not associated with less severe disease, lower ASP scores or less frequent abnormal cardiovascular function test results.
Male sexual function and autonomic control of the cardiovascular system are nearly normal in Fabry patients, which cast doubt on the general accepted assumption that autonomic neuropathy is the main cause of symptoms and signs compatible with autonomic dysfunction in Fabry disease. Possibly, end-organ damage plays a key role in the development of symptoms and signs in Fabry patients. An exceptional kind of autonomic neuropathy is another but less likely explanation.
法布里病患者有与自主功能障碍相符的症状和体征。这些症状和体征被认为是由于外周神经系统受损所致,但其他疾病(如直立不耐受和男性性功能障碍)中提示自主神经病变的发现却很少在法布里病中报告。我们的研究目的是调查大量男性和女性法布里病患者的自主症状和心血管自主功能。
48 名法布里病患者(15 名男性,30 名接受酶替代治疗)和 48 名性别和年龄匹配的对照者完成了自主症状问卷(自主症状概况)。36 名法布里病患者接受了心血管功能测试。
自主症状概况显示,法布里病患者的总分明显高于健康对照组(22 分比 12 分),但与已证实的自主神经病变患者相比得分相对较低。法布里病患者在直立不耐受域的评分比健康对照组差。健康对照组和男性法布里病患者在男性性功能障碍域的评分相当。心血管自主功能测试仅在 7 名患者中发现轻度异常。这 7 名患者中没有一人出现超过一项异常测试结果。酶替代治疗与疾病严重程度较轻、ASP 评分较低或心血管功能测试结果异常频率较低无关。
男性性功能和心血管系统的自主控制在法布里病患者中几乎正常,这对自主神经病变是法布里病中与自主功能障碍相符的症状和体征的主要原因这一普遍接受的假设提出了质疑。可能,终末器官损伤在法布里病患者症状和体征的发展中起着关键作用。另一种不太可能的解释是一种特殊类型的自主神经病变。